title: Diminished anticoagulant and fibrinolytic activity following liver transplantation.
abstract: This study analyzed the coagulation changes in twenty patients after orthotopic liver transplantation. The procoagulant, anticoagulant, and fibrinolytic systems were studied during the first two postoperative weeks. Within the first postoperative day all extrinsic and intrinsic pathway factors became normal except factors IX, VII, and X, which recovered within the next 24 hr. Of interest are the changes in factor VIII, which reached a high concentration with an increase in its antigenic fraction during the study. However, coagulation inhibitors showed a different pattern. In fact, antithrombin III (AT-III) and protein C (PC) needed from 7 to 14 days to reach normal values. Total protein S (TPS) and free protein S (FPS) did not recover until day 7, whereas heparin cofactor II (HC-II) remained at subnormal levels throughout the study. Thrombin-antithrombin III complex (TAT) values were strikingly elevated in the immediate postoperative period. Fibrinolysis parameters showed plasminogen (PL) levels in the normal range until day 4. Antiplasmin (AP) followed a curve parallel to that of plasminogen but its levels were higher during this observation period. Similarly the initial elevation in plasminogen activator inhibitor 1 endothelial type (PAI-1) levels remained high until days 4 and 7. In summary, it can be concluded that during the postoperative phase after OLT a hypercoagulable state is developed as a result of diminished anticoagulant and fibrinolytic activity. This coagulation might be a nontechnical factor contributing to the thrombotic vascular complications of some liver recipients.
authors.affiliation: Department of Haematology, University Hospital Reina Sofia, Cordoba, Spain.
authors.forename: F
authors.initials: F
authors.lastname: Velasco
authors.forename: R
authors.initials: R
authors.lastname: Villalba
authors.forename: M
authors.initials: M
authors.lastname: Fernandez
authors.forename: M
authors.initials: M
authors.lastname: de la Mata
authors.forename: J
authors.initials: J
authors.lastname: Roman
authors.forename: V
authors.initials: V
authors.lastname: Rubio
authors.forename: S
authors.initials: S
authors.lastname: Rufian
authors.forename: E
authors.initials: E
authors.lastname: Varo
authors.forename: C
authors.initials: C
authors.lastname: Pera
authors.forename: A
authors.initials: A
authors.lastname: Torres
mesh_terms: D000293:Adolescent; D000328:Adult; D000990:Antithrombin III / Q000032:analysis; D001157:Arterial Occlusive Diseases / Q000209:etiology; D001777:Blood Coagulation / Q000502:physiology*; D005260:Female; D005342:Fibrinolysis / Q000502:physiology*; D006499:Hepatic Artery; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D010447:Peptide Hydrolases / Q000032:analysis
chemical_list: C046193:antithrombin III-protease complex; D000990:Antithrombin III; D010447:Peptide Hydrolases